Metabolic dysfunction-associated steatotic liver disease

  • HOME
  • TOPICS
  • Metabolic dysfunction-associated steatotic liver disease
2125
Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
Xiao-Dong Zhou, Terry Cheuk-Fung Yip, Daniel Q Huang, Mark Dhinesh Muthiah, Mazen Noureddin, Ming-Hua Zheng
Clin Mol Hepatol. 2025;31(2):620-624.   Published online December 26, 2024
View: 1710   Download: 64  Web of Science: 2  Crossref: 3
2090
Stabilizing hepatic fatty acid oxidation: Editorial on “USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination”
Myeung Gi Choi, Na Young Lee, Ja Hyun Koo
Clin Mol Hepatol. 2025;31(2):592-595.   Published online November 6, 2024
View: 1520   Download: 85
Original Article
2113
GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Xiao-Chen Ma, Chen-He Yi, Bao-Rui Tao, Bo Zhang, Yue Ma, Guo Zhang, Rui Zhang, Yan Geng, Jing Lin, Jin-Hong Chen
Clin Mol Hepatol. 2025;31(2):409-425.   Published online December 10, 2024
View: 2489   Download: 287  Web of Science: 7  Crossref: 7
2109
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clin Mol Hepatol. 2025;31(2):382-393.   Published online November 29, 2024
View: 3628   Download: 472  Web of Science: 11  Crossref: 15
Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
Clin Mol Hepatol. 2025;31(2):e186-e188.   Published online January 24, 2025
View: 778   Download: 37  Web of Science: 1  Crossref: 1
Reply to Correspondence
Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
Jing Zeng, Jian-Gao Fan
Clin Mol Hepatol. 2025;31(2):e218-e220.   Published online February 3, 2025
View: 803   Download: 28
Correspondence
GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
Clin Mol Hepatol. 2025;31(2):e189-e191.   Published online February 13, 2025
View: 775   Download: 30  Crossref: 1
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clin Mol Hepatol. 2025;31(2):e180-e182.   Published online February 13, 2025
View: 791   Download: 24
Reply to Correspondence
Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yoon-su Ha, Won Kim, Seung-Jin Kim
Clin Mol Hepatol. 2025;31(2):e226-e227.   Published online February 13, 2025
View: 1045   Download: 30
Correspondence
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clin Mol Hepatol. 2025;31(2):e183-e185.   Published online February 17, 2025
View: 791   Download: 15  Crossref: 1
Letter to the Editor
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
Wei Wang, Yating Xie, Ailei Xu
Clin Mol Hepatol. 2025;31(2):e143-e144.   Published online February 18, 2025
View: 791   Download: 35
Reply to Correspondence
Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Nahee Hwang, Sungsoon Fang
Clin Mol Hepatol. 2025;31(2):e228-e231.   Published online February 26, 2025
View: 846   Download: 26
Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Jeayeon Park, Su Jong Yu
Clin Mol Hepatol. 2025;31(2):e221-e223.   Published online March 4, 2025
View: 628   Download: 8
Review
1954
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2025;31(Suppl):S51-S75.   Published online June 27, 2024
View: 6434   Download: 238  Web of Science: 3  Crossref: 3
1997
Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
Andrea Caddeo, Stefano Romeo
Clin Mol Hepatol. 2025;31(Suppl):S76-S93.   Published online August 5, 2024
View: 3711   Download: 448  Web of Science: 8  Crossref: 11
2010
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clin Mol Hepatol. 2025;31(Suppl):S32-S50.   Published online August 19, 2024
View: 15558   Download: 1,995  Web of Science: 68  Crossref: 71
2107
Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease
Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan S. Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan
Clin Mol Hepatol. 2025;31(Suppl):S94-S111.   Published online November 28, 2024
View: 4531   Download: 343  Web of Science: 5  Crossref: 10
Special Issue
2190
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang, on behalf of The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol. 2025;31(Suppl):S1-S31.   Published online February 19, 2025
View: 1492   Download: 176  Web of Science: 2  Crossref: 3
Snapshot
1993
Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
Clara Meda, Arianna Dolce, Sara Della Torre
Clin Mol Hepatol. 2025;31(1):327-332.   Published online August 5, 2024
View: 1494   Download: 88

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2898
TOTAL : 2790589
Close layer